Dorling Janet
Insider CIK 1738144 · CBAY Chief Commercial Officer, Director · AKAO Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 55,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-02-12 | 2024-02-14 | 6,000 | — | $0 | 55,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-02-12 | 2024-02-14 | 6,000 | $31.97 | $191.8K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-02-12 | 2024-02-14 | 6,000 | $4.63 | $27.8K | 6,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-10 | 2024-01-10 | 6,000 | — | $0 | 61,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-10 | 2024-01-10 | 6,000 | $4.63 | $27.8K | 6,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-10 | 2024-01-10 | 6,000 | $23.86 | $143.2K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-11 | 2023-12-11 | 6,000 | — | $0 | 67,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-11 | 2023-12-11 | 6,000 | $4.63 | $27.8K | 6,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-11 | 2023-12-11 | 6,000 | $20.07 | $120.4K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-10 | 2023-11-14 | 7,000 | — | $0 | 73,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-11-10 | 2023-11-14 | 7,000 | $15.24 | $106.7K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-11-10 | 2023-11-14 | 7,000 | $4.63 | $32.4K | 7,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 67,000 | — | $0 | 67,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-04-05 | 2021-04-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-08-05 | 2019-08-05 | 341,000 | — | $0 | 341,000 | SEC↗ |
| AKAO Achaogen, Inc. | S Sale | 2019-02-21 | 2019-02-25 | 1,063 | $0.89 | $946 | 284,738 | SEC↗ |
| AKAO Achaogen, Inc. | S Sale | 2019-02-05 | 2019-02-07 | 818 | $1.35 | $1.1K | 285,801 | SEC↗ |
| AKAO Achaogen, Inc. | A Award | 2019-01-18 | 2019-01-23 | 187,800 | — | $0 | 286,619 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2018-09-11 | 2018-09-13 | 80,000 | — | $0 | 80,000 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2018-06-26 | 2018-06-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AKAO Achaogen Inc | S Sale | 2018-06-26 | 2018-06-28 | 450 | $9.59 | $4.3K | 23,819 | SEC↗ |
| AKAO Achaogen Inc | A Award | 2018-06-26 | 2018-06-28 | 1,300 | — | $0 | 24,269 | SEC↗ |